City

Dallas (2)

Condition

Nonhematologic Malignancies (2)

Lymphoma (1)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Metronome Therapeutics (1)

Millennium Pharmaceuticals, Inc. (1)

Collaborator

Intervention

clarithromycin (1)

ixazomib 2.5 mg (1)

ixazomib 4 mg capsule a (1)

ixazomib 4 mg capsule b (1)

ketoconazole (1)

rifampin (1)

vinorelbine tartrate (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

nonhematologic malignancies

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Nonhematologic Malignancies, Lymphoma Trial in Dallas (Ixazomib 2.5 mg, Ixazomib 4 mg Capsule A, Ixazomib 4 mg Capsule B)

Completed

Nonhematologic Malignancies
Lymphoma

Ixazomib 2.5 mg
+5 more

Dallas, Texas

(unnamed)

Jun 16, 2017

Nonhematologic Malignancies Trial in Dallas (vinorelbine tartrate)

Unknown status

Nonhematologic Malignancies

vinorelbine tartrate

Dallas, Texas

Texas Oncology PA; Sammons Cancer Center

Sep 24, 2008